[96a5a0]: / output / allTrials / identified / NCT05802420_identified.json

Download this file

234 lines (234 with data), 9.3 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
{
"info": {
"nct_id": "NCT05802420",
"official_title": "The Value of Molecular Residual Disease Monitoring Based on ctDNA in Advanced or Metastatic Pancreatic Cancer",
"inclusion_criteria": "* patients with histologically confirmed unresectable advanced or metastatic pancreatic cancer;\n* both sexes, age ≥18 years old;\n* ECOG performance status score ≤2;\n* the expected survival time was ≥3 months.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* a known diagnosis of pancreatic cancer other than ductal adenocarcinoma;\n* treated with any systemic antitumor treatment before first-line chemotherapy onset;\n* died or lost to follow-up within one month after the initiation of first-line chemotherpay;\n* combined with other primary malignances.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* patients with histologically confirmed unresectable advanced or metastatic pancreatic cancer;",
"criterions": [
{
"exact_snippets": "histologically confirmed",
"criterion": "histological confirmation",
"requirements": [
{
"requirement_type": "confirmation",
"expected_value": true
}
]
},
{
"exact_snippets": "unresectable",
"criterion": "resectability of pancreatic cancer",
"requirements": [
{
"requirement_type": "resectability",
"expected_value": false
}
]
},
{
"exact_snippets": "advanced or metastatic pancreatic cancer",
"criterion": "stage of pancreatic cancer",
"requirements": [
{
"requirement_type": "stage",
"expected_value": [
"advanced",
"metastatic"
]
}
]
}
]
},
{
"line": "* both sexes, age ≥18 years old;",
"criterions": [
{
"exact_snippets": "both sexes",
"criterion": "sex",
"requirements": [
{
"requirement_type": "allowed",
"expected_value": [
"male",
"female"
]
}
]
},
{
"exact_snippets": "age ≥18 years old",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
]
}
]
},
{
"line": "* ECOG performance status score ≤2;",
"criterions": [
{
"exact_snippets": "ECOG performance status score ≤2",
"criterion": "ECOG performance status score",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": "<=",
"value": 2,
"unit": "N/A"
}
}
]
}
]
},
{
"line": "* the expected survival time was ≥3 months.",
"criterions": [
{
"exact_snippets": "expected survival time was ≥3 months",
"criterion": "expected survival time",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 3,
"unit": "months"
}
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* a known diagnosis of pancreatic cancer other than ductal adenocarcinoma;",
"criterions": [
{
"exact_snippets": "a known diagnosis of pancreatic cancer other than ductal adenocarcinoma",
"criterion": "pancreatic cancer diagnosis",
"requirements": [
{
"requirement_type": "type",
"expected_value": "other than ductal adenocarcinoma"
}
]
}
]
},
{
"line": "* treated with any systemic antitumor treatment before first-line chemotherapy onset;",
"criterions": [
{
"exact_snippets": "treated with any systemic antitumor treatment before first-line chemotherapy onset",
"criterion": "prior systemic antitumor treatment",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* combined with other primary malignances.",
"criterions": [
{
"exact_snippets": "combined with other primary malignances",
"criterion": "primary malignancies",
"requirements": [
{
"requirement_type": "combination",
"expected_value": true
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [
{
"line": "* died or lost to follow-up within one month after the initiation of first-line chemotherpay;",
"criterions": [
{
"exact_snippets": "died ... within one month after the initiation of first-line chemotherapy",
"criterion": "mortality",
"requirements": [
{
"requirement_type": "time frame",
"expected_value": "within one month after the initiation of first-line chemotherapy"
}
]
},
{
"exact_snippets": "lost to follow-up within one month after the initiation of first-line chemotherapy",
"criterion": "follow-up status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "lost"
},
{
"requirement_type": "time frame",
"expected_value": "within one month after the initiation of first-line chemotherapy"
}
]
}
]
}
],
"failed_miscellaneous": []
}